Gerard Silvestri to Lung Neoplasms
This is a "connection" page, showing publications Gerard Silvestri has written about Lung Neoplasms.
Connection Strength
31.069
-
Why Are Women More Likely to Be Overdiagnosed With Lung Cancer? Chest. 2023 01; 163(1):22-24.
Score: 0.459
-
Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study. Ann Intern Med. 2022 Nov; 175(11):1501-1505.
Score: 0.452
-
Factors Associated With Smoking Cessation Attempts in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial. Chest. 2023 02; 163(2):433-443.
Score: 0.450
-
Shared Decision-Making During a Lung Cancer Screening Visit: Is It a Barrier or Does It Bring Value? Chest. 2023 01; 163(1):251-254.
Score: 0.446
-
Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists. Cancer Med. 2022 01; 11(2):530-538.
Score: 0.427
-
Reducing Disparities in Lung Cancer Screening: It's Not So Black and White. J Natl Cancer Inst. 2021 11 02; 113(11):1447-1448.
Score: 0.423
-
Lung Cancer Screening Eligibility and Screening Patterns Among Black and White Adults in the United States. JAMA Netw Open. 2021 10 01; 4(10):e2130350.
Score: 0.421
-
State Variation in Low-Dose?Computed Tomography Scanning for Lung Cancer Screening in the United States. J Natl Cancer Inst. 2021 08 02; 113(8):1044-1052.
Score: 0.416
-
Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer. Chest. 2021 12; 160(6):2293-2303.
Score: 0.413
-
Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2021 03; 159(3):1283-1287.
Score: 0.395
-
Incorporating Baseline Lung Function in Lung Cancer Screening: Does a "Lung Health Check" Help Predict Outcomes? Chest. 2021 04; 159(4):1664-1669.
Score: 0.395
-
Robotic Bronchoscopy for Peripheral Pulmonary Lesions: A Multicenter Pilot and Feasibility Study (BENEFIT). Chest. 2021 02; 159(2):845-852.
Score: 0.389
-
Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017. J Cancer Educ. 2020 08; 35(4):678-681.
Score: 0.388
-
Strange Bedfellows: The Interaction between COPD and Lung Cancer in the Context of Lung Cancer Screening. Ann Am Thorac Soc. 2020 07; 17(7):810-812.
Score: 0.386
-
Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening. Chest. 2020 11; 158(5):2184-2191.
Score: 0.385
-
Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020 10; 158(4):1742-1752.
Score: 0.383
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415.
Score: 0.381
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. J Am Coll Radiol. 2020 Jul; 17(7):845-854.
Score: 0.381
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Radiol Imaging Cancer. 2020 05; 2(3):e204013.
Score: 0.381
-
An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer. Chest. 2020 06; 157(6):1656-1664.
Score: 0.374
-
Accuracy of a Robotic Endoscopic System in Cadaver Models with Simulated Tumor Targets: ACCESS Study. Respiration. 2020; 99(1):56-61.
Score: 0.371
-
Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial. JAMA Intern Med. 2019 12 01; 179(12):1710-1712.
Score: 0.370
-
Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons. Clin Lung Cancer. 2020 03; 21(2):e89-e98.
Score: 0.359
-
Setting the Stage for Success in Lung Cancer: The Importance of Remembering Your (Guide)Lines. Chest. 2019 03; 155(3):456-457.
Score: 0.352
-
In-person and Telephonic Shared Decision-making Visits for People Considering Lung Cancer Screening: An Assessment of Decision Quality. Chest. 2019 01; 155(1):236-238.
Score: 0.348
-
Shared Decision-making and Lung Cancer Screening: Let's Get the Conversation Started. Chest. 2019 01; 155(1):21-24.
Score: 0.343
-
Smoking Trends and Lung Cancer Mortality: The Good, the Bad, and the Ugly. Ann Intern Med. 2018 11 20; 169(10):721-722.
Score: 0.342
-
Standard Bronchoscopy With Fluoroscopy vs Thin Bronchoscopy and Radial Endobronchial Ultrasound for Biopsy of Pulmonary Lesions: A Multicenter, Prospective, Randomized Trial. Chest. 2018 11; 154(5):1035-1043.
Score: 0.339
-
A Patient-Centered Activity Regimen Improves Participation in Physical Activity Interventions in Advanced-Stage Lung Cancer. Integr Cancer Ther. 2018 09; 17(3):921-927.
Score: 0.335
-
Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500.
Score: 0.328
-
Low-dose CT for lung cancer screening. Lancet Oncol. 2018 03; 19(3):e133-e134.
Score: 0.328
-
Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease. Am J Respir Crit Care Med. 2017 09 01; 196(5):602-608.
Score: 0.317
-
Comparing Pulmonary Nodule Location During Electromagnetic Bronchoscopy With Predicted Location on the Basis of Two Virtual Airway Maps at Different Phases of?Respiration. Chest. 2018 01; 153(1):181-186.
Score: 0.312
-
Viewing All the Trees in the Forest: The Importance of Reporting Abnormal Findings on CT Scan When Screening for Lung Cancer. Chest. 2017 03; 151(3):525-526.
Score: 0.306
-
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
Score: 0.304
-
Assessing the Correlation Between Physical Activity and Quality of Life in Advanced Lung Cancer. Integr Cancer Ther. 2018 03; 17(1):73-79.
Score: 0.302
-
Palliative Care in Lung Cancer: A Review. Semin Respir Crit Care Med. 2016 10; 37(5):750-759.
Score: 0.298
-
The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41.
Score: 0.286
-
Peripheral Bronchoscopy Training Using a Human Cadaveric Model and Simulated Tumor Targets. J Bronchology Interv Pulmonol. 2016 Jan; 23(1):83-6.
Score: 0.282
-
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
Score: 0.281
-
Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med. 2015 Jul 15; 192(2):200-8.
Score: 0.273
-
Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application. J Thorac Oncol. 2015 Jun; 10(6):861-71.
Score: 0.271
-
A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer. N Engl J Med. 2015 Jul 16; 373(3):243-51.
Score: 0.270
-
Screening for Lung Cancer Using Low-Dose Computed Tomography. Are We Headed for DANTE's Paradise or Inferno? Am J Respir Crit Care Med. 2015 May 15; 191(10):1100-1.
Score: 0.270
-
Reply: Lung Cancer Screening: The Balance between Harm and Benefit. Am J Respir Crit Care Med. 2015 May 15; 191(10):1209-10.
Score: 0.270
-
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest. 2015 Feb; 147(2):295-303.
Score: 0.265
-
Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
Score: 0.263
-
Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
Score: 0.256
-
Response. Chest. 2014 Aug; 146(2):e70.
Score: 0.256
-
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
Score: 0.249
-
Attitudes and beliefs toward lung cancer screening among US Veterans. Chest. 2013 Dec; 144(6):1783-1787.
Score: 0.244
-
Simultaneously diagnosing and staging lung cancer: a win-win for the patient and the health-care system. Chest. 2013 Dec; 144(6):1747-1749.
Score: 0.244
-
Diagnostic approach to the solitary pulmonary nodule. Semin Respir Crit Care Med. 2013 Dec; 34(6):762-9.
Score: 0.244
-
Computed tomography screening for lung cancer. Ann Intern Med. 2013 Jul 16; 159(2):155-6.
Score: 0.238
-
Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e211S-e250S.
Score: 0.235
-
Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest. 2012 Aug; 142(2):385-393.
Score: 0.223
-
Bronchoscopy for the solitary pulmonary nodule: friend or foe? Chest. 2012 Aug; 142(2):276-277.
Score: 0.223
-
Current status of tobacco policy and control. J Thorac Imaging. 2012 Jul; 27(4):213-9.
Score: 0.221
-
Lung cancer screening practices of primary care physicians: results from a national survey. Ann Fam Med. 2012 Mar-Apr; 10(2):102-10.
Score: 0.216
-
New testing for lung cancer screening. Oncology (Williston Park). 2012 Feb; 26(2):176-82.
Score: 0.215
-
The role of molecular analyses in the era of personalized therapy for advanced NSCLC. Lung Cancer. 2012 May; 76(2):131-7.
Score: 0.213
-
A decade of advances in treatment of early-stage lung cancer. Clin Chest Med. 2011 Dec; 32(4):827-38.
Score: 0.211
-
Screening for lung cancer: it works, but does it really work? Ann Intern Med. 2011 Oct 18; 155(8):537-9.
Score: 0.209
-
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011 Dec; 140(6):1550-1556.
Score: 0.206
-
Influence of nodule detection software on radiologists' confidence in identifying pulmonary nodules with computed tomography. J Thorac Imaging. 2011 Feb; 26(1):48-53.
Score: 0.201
-
You just can't call it lung cancer anymore. J Thorac Oncol. 2011 Feb; 6(2):239-40.
Score: 0.201
-
An up to date look at lung cancer screening. Cell Adh Migr. 2010 Jan-Mar; 4(1):96-9.
Score: 0.187
-
The changing epidemiology of lung cancer with a focus on screening. BMJ. 2009 Aug 17; 339:b3053.
Score: 0.182
-
Endobronchial ultrasound for the diagnosis and staging of lung cancer. Proc Am Thorac Soc. 2009 Apr 15; 6(2):180-6.
Score: 0.177
-
Imprecision in automated volume measurements of pulmonary nodules and its effect on the level of uncertainty in volume doubling time estimation. Chest. 2009 Jun; 135(6):1580-1587.
Score: 0.174
-
Barriers to hospice enrollment among lung cancer patients: a survey of family members and physicians. Palliat Support Care. 2008 Dec; 6(4):357-62.
Score: 0.173
-
Lung cancer: evolving concepts. Semin Respir Crit Care Med. 2008 Jun; 29(3):221-2.
Score: 0.167
-
Bronchoscopy for the diagnosis and staging of lung cancer. Semin Respir Crit Care Med. 2008 Jun; 29(3):261-70.
Score: 0.167
-
Pulmonary nodule volume: effects of reconstruction parameters on automated measurements--a phantom study. Radiology. 2008 May; 247(2):400-8.
Score: 0.166
-
Deaths among patients with screen-detected lung cancer. Clin Cancer Res. 2008 Apr 15; 14(8):2511; author reply 2511-2.
Score: 0.165
-
Screening for lung cancer. AJR Am J Roentgenol. 2008 Mar; 190(3):755-61.
Score: 0.164
-
Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration. Ann Thorac Surg. 2008 Jan; 85(1):224-30.
Score: 0.162
-
Lung cancer screening. Am J Med Sci. 2008 Jan; 335(1):46-50.
Score: 0.162
-
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):178S-201S.
Score: 0.158
-
A seismic shift in staging. J Thorac Oncol. 2007 Aug; 2(8):682-3.
Score: 0.158
-
A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease. Chest. 2007 Jun; 131(6):1794-9.
Score: 0.155
-
CT screening for lung cancer. N Engl J Med. 2007 Feb 15; 356(7):745; author reply 746-7.
Score: 0.153
-
Screening for lung cancer in a high-risk group: but I still haven't found what I'm looking for... Eur Respir J. 2007 Jan; 29(1):6-7.
Score: 0.151
-
Carcinoma of the bronchus 60 years later. Thorax. 2006 Dec; 61(12):1023-8.
Score: 0.150
-
Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax. 2007 Feb; 62(2):126-30.
Score: 0.150
-
Successful real-time endobronchial ultrasound-guided transbronchial needle aspiration of a hilar lung mass obtained by traversing the pulmonary artery. J Thorac Oncol. 2006 May; 1(4):362-4.
Score: 0.144
-
A tale of two cities: comparing lung cancer outcomes in Teesside, UK and Varese, Italy. Thorax. 2006 Mar; 61(3):188.
Score: 0.143
-
Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest. 2005 Dec; 128(6):3975-84.
Score: 0.140
-
Usefulness of transbronchial needle aspiration in evaluating patients with lung cancer. Thorax. 2005 Nov; 60(11):890-1.
Score: 0.140
-
The treatment of advanced non-small cell lung cancer. Curr Opin Pulm Med. 2005 Jul; 11(4):287-91.
Score: 0.136
-
One hundred years of lung cancer. Am J Respir Crit Care Med. 2005 Sep 01; 172(5):523-9.
Score: 0.136
-
Chemotherapy for advanced lung cancer: is the glass half full or half empty? Thorax. 2004 Oct; 59(10):821.
Score: 0.129
-
The role of radiotherapy and chemotherapy for curative management of medically inoperable and stage III nonsmall cell lung cancer, and radiotherapy for palliation of symptomatic disease. Respir Care Clin N Am. 2003 Jun; 9(2):163-90.
Score: 0.118
-
Glutathione S-transferase M1 polymorphism and the risk of lung cancer. Anticancer Res. 2003 May-Jun; 23(3A):2111-24.
Score: 0.117
-
One from column A: choosing between CT, positron emission tomography, endoscopic ultrasound with fine-needle aspiration, transbronchial needle aspiration, thoracoscopy, mediastinoscopy, and mediastinotomy for staging lung cancer. Chest. 2003 Feb; 123(2):333-5.
Score: 0.115
-
The noninvasive staging of non-small cell lung cancer: the guidelines. Chest. 2003 Jan; 123(1 Suppl):147S-156S.
Score: 0.115
-
Caring for the dying patient with lung cancer. Chest. 2002 Sep; 122(3):1028-36.
Score: 0.112
-
What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest. 2002 Jul; 122(1):21-30.
Score: 0.111
-
Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study. BMJ Open. 2022 06 22; 12(6):e064142.
Score: 0.111
-
Factors Associated With Lung Cancer Screening Adherence Among Patients With Negative Baseline CT Results in a Community Health Care Setting. J Am Coll Radiol. 2022 02; 19(2 Pt A):232-239.
Score: 0.106
-
Pretreatment Invasive Nodal Staging in Lung Cancer: Knowledge, Attitudes, and Beliefs Among Academic and Community Physicians. Chest. 2022 03; 161(3):826-832.
Score: 0.106
-
Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017-2019. Ann Am Thorac Soc. 2021 11; 18(11):1886-1893.
Score: 0.106
-
Lung Cancer Screening Rates During the COVID-19 Pandemic. Chest. 2022 02; 161(2):586-589.
Score: 0.104
-
Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report. Chest. 2021 11; 160(5):1959-1980.
Score: 0.104
-
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2021 11; 160(5):e427-e494.
Score: 0.104
-
Tobacco Treatment Specialist Training for Lung Cancer Screening Providers. Am J Prev Med. 2021 11; 61(5):765-768.
Score: 0.103
-
"Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study". BMC Cancer. 2021 Apr 01; 21(1):352.
Score: 0.102
-
Performance of Risk Factor-Based Guidelines and Model-Based Chest CT Lung Cancer Screening in World Trade Center-Exposed Fire Department Rescue/Recovery Workers. Chest. 2021 05; 159(5):2060-2071.
Score: 0.099
-
Palliation for the dying patient with lung cancer. Respir Care. 2000 Dec; 45(12):1490-6; discussion 1497-500.
Score: 0.099
-
Diagnosis and staging of lung cancer. Clin Chest Med. 2000 Mar; 21(1):95-106, viii-ix.
Score: 0.094
-
First-in-Human Use of a Hybrid Real-Time Ultrasound-Guided Fine-Needle Acquisition System for Peripheral Pulmonary Lesions: A Multicenter Pilot Study. Respiration. 2019; 98(6):527-533.
Score: 0.092
-
Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done. Ann Am Thorac Soc. 2019 11; 16(11):1360-1362.
Score: 0.092
-
Patient-Level Trajectories and Outcomes After Low-Dose CT Screening in the National Lung Screening Trial. Chest. 2019 11; 156(5):965-971.
Score: 0.090
-
Commentary: Invasive mediastinal staging for lung cancer-Quality gap, evidence gap, both? J Thorac Cardiovasc Surg. 2019 10; 158(4):1232-1233.
Score: 0.089
-
Evaluating Lung Cancer Screening Uptake, Outcomes, and Costs in the United States: Challenges With Existing Data and Recommendations for Improvement. J Natl Cancer Inst. 2019 04 01; 111(4):342-349.
Score: 0.088
-
Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from?the National Lung Cancer Roundtable. J Thorac Oncol. 2019 03; 14(3):338-342.
Score: 0.087
-
Safety and diagnostic performance of pulmonologists performing electromagnetic guided percutaneous lung biopsy (SPiNperc). Respirology. 2019 05; 24(5):453-458.
Score: 0.087
-
Response. Chest. 2018 10; 154(4):997-998.
Score: 0.085
-
Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ. 1998 Sep 19; 317(7161):771-5.
Score: 0.085
-
Specialists achieve better outcomes than generalists for lung cancer surgery. Chest. 1998 Sep; 114(3):675-80.
Score: 0.085
-
Response. Chest. 2018 09; 154(3):716-717.
Score: 0.085
-
Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018 07 15; 198(2):e3-e13.
Score: 0.084
-
Surrogate Markers and the Association of Low-Dose CT Lung Cancer Screening With Mortality. JAMA Oncol. 2018 07 01; 4(7):1006-1008.
Score: 0.084
-
Study Design and Rationale: A Multicenter, Prospective Trial of Electromagnetic Bronchoscopic and Electromagnetic Transthoracic Navigational Approaches for the Biopsy of Peripheral Pulmonary Nodules (ALL IN ONE Trial). Contemp Clin Trials. 2018 08; 71:88-95.
Score: 0.084
-
Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018 07; 154(1):110-118.
Score: 0.083
-
Reviewing Lung Cancer Screening: The Who, Where, When, Why, and How. Clin Chest Med. 2018 03; 39(1):31-43.
Score: 0.082
-
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2018 04; 153(4):954-985.
Score: 0.082
-
Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2017 11 01; 196(9):1202-1212.
Score: 0.080
-
Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement. Am J Respir Crit Care Med. 2017 10 01; 196(7):e15-e29.
Score: 0.080
-
Underuse of Chest Radiography Versus Computed Tomography for Lung Cancer Screening. Am J Public Health. 2017 08; 107(8):1248-1250.
Score: 0.079
-
Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival. Chest. 2017 09; 152(3):587-597.
Score: 0.077
-
Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study. Ann Am Thorac Soc. 2016 11; 13(11):1977-1982.
Score: 0.075
-
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
Score: 0.074
-
Pulmonary blastoma: a rare lung malignancy. Lung Cancer. 1996 Sep; 15(2):233-7.
Score: 0.074
-
Endoscopic ultrasound with fine-needle aspiration in the diagnosis and staging of lung cancer. Ann Thorac Surg. 1996 May; 61(5):1441-5; discussion 1445-6.
Score: 0.072
-
Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer. Chest. 2016 Jul; 150(1):210-8.
Score: 0.071
-
Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository. BMC Pulm Med. 2016 Jan 22; 16:16.
Score: 0.071
-
Technical Aspects of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: CHEST Guideline and Expert Panel Report. Chest. 2016 Mar; 149(3):816-35.
Score: 0.071
-
Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest. 1995 Nov; 108(5):1264-71.
Score: 0.070
-
Pulmonary Lung Cancer Subspecialty Training. J Bronchology Interv Pulmonol. 2015 Oct; 22(4):281-5.
Score: 0.069
-
The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. Am J Respir Crit Care Med. 1995 Jul; 152(1):225-30.
Score: 0.068
-
Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy. BMC Med Genomics. 2015 May 06; 8:18.
Score: 0.067
-
Screening and early detection efforts in lung cancer. Cancer. 2015 May 01; 121(9):1347-56.
Score: 0.066
-
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med. 2014 Dec; 11(12):e1001764.
Score: 0.065
-
Factors that influence physician decision making for indeterminate pulmonary nodules. Ann Am Thorac Soc. 2014 Dec; 11(10):1586-91.
Score: 0.065
-
Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med. 2014 Nov 06; 371(19):1793-802.
Score: 0.065
-
Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant. Ann Am Thorac Soc. 2013 Dec; 10(6):629-35.
Score: 0.061
-
Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med. 2013 Jul 18; 369(3):245-254.
Score: 0.060
-
Activation of p53 with Nutlin-3a radiosensitizes lung cancer cells via enhancing radiation-induced premature senescence. Lung Cancer. 2013 Aug; 81(2):167-73.
Score: 0.059
-
Selection criteria for lung-cancer screening. N Engl J Med. 2013 Feb 21; 368(8):728-36.
Score: 0.058
-
Invited commentary: the etiology of lung cancer in men compared with women. Am J Epidemiol. 2013 Apr 01; 177(7):613-6.
Score: 0.058
-
The relationship of clinical findings to CT scan evidence of adrenal gland metastases in the staging of bronchogenic carcinoma. Chest. 1992 Dec; 102(6):1748-51.
Score: 0.057
-
Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol. 2012 Feb; 7(2):365-9.
Score: 0.054
-
Evaluation and treatment of high-risk patients with early-stage lung cancer. Clin Chest Med. 2011 Dec; 32(4):783-97.
Score: 0.053
-
High-dose fractionated radiotherapy to 80 Gy for stage I-II medically inoperable non-small-cell lung cancer. J Med Imaging Radiat Oncol. 2010 Dec; 54(6):554-61.
Score: 0.050
-
U.S. primary care physicians' lung cancer screening beliefs and recommendations. Am J Prev Med. 2010 Nov; 39(5):411-20.
Score: 0.049
-
Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival. J Med Imaging Radiat Oncol. 2010 Oct; 54(5):483-9.
Score: 0.049
-
Lung cancer: progress in diagnosis, staging and therapy. Respirology. 2010 Jan; 15(1):44-50.
Score: 0.047
-
The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina. Ann Epidemiol. 2009 May; 19(5):304-10.
Score: 0.044
-
Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg. 2008 Jul; 86(1):220-6; discussion 227.
Score: 0.042
-
Variation in experts' beliefs about lung cancer growth, progression, and prognosis. J Thorac Oncol. 2008 Apr; 3(4):422-6.
Score: 0.041
-
Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax. 2008 Apr; 63(4):335-41.
Score: 0.040
-
Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):69S-77S.
Score: 0.040
-
Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):202S-220S.
Score: 0.040
-
A 69-year-old with lung mass and mediastinal lymphadenopathy on chest computed tomography. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):908-11.
Score: 0.039
-
Boys (and girls) and their toys: a look at new technologies in the bronchoscopy suite. Am J Respir Crit Care Med. 2007 Jul 01; 176(1):1-2.
Score: 0.039
-
Lung and bronchus cancer disparities in South Carolina: epidemiology and strategies for prevention. J S C Med Assoc. 2006 Aug; 102(7):183-91.
Score: 0.037
-
Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis. J Thorac Oncol. 2006 Feb; 1(2):112-9.
Score: 0.036
-
Multidisciplinary management of lung cancer. N Engl J Med. 2004 May 06; 350(19):2008-10; author reply 2008-10.
Score: 0.031
-
Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography. Ann Thorac Surg. 2004 May; 77(5):1763-8.
Score: 0.031
-
Accuracy of EUS criteria and primary tumor site for identification of mediastinal lymph node metastasis from non-small-cell lung cancer. Gastrointest Endosc. 2004 Feb; 59(2):205-12.
Score: 0.031
-
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003 Dec; 126(6):1943-51.
Score: 0.031
-
Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn. 2003 Nov; 5(4):237-42.
Score: 0.030
-
Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med. 2003 Oct 07; 139(7):558-63.
Score: 0.030
-
Importance of faith on medical decisions regarding cancer care. J Clin Oncol. 2003 Apr 01; 21(7):1379-82.
Score: 0.029
-
Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. Am J Respir Crit Care Med. 2003 Jun 15; 167(12):1670-5.
Score: 0.029
-
Lung cancer. Invasive staging: the guidelines. Chest. 2003 Jan; 123(1 Suppl):167S-175S.
Score: 0.029
-
Endoscopic ultrasound-guided fine needle aspiration for staging patients with carcinoma of the lung. Ann Thorac Surg. 2001 Dec; 72(6):1861-7.
Score: 0.027
-
Cost-efficacy of endoscopic ultrasonography with fine-needle aspiration vs. mediastinotomy in patients with lung cancer and suspected mediastinal adenopathy. Endoscopy. 1999 Nov; 31(9):707-11.
Score: 0.023
-
Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer. Am Rev Respir Dis. 1992 Sep; 146(3):707-10.
Score: 0.014
-
Pulmonary complications of radiation therapy. Clin Chest Med. 2004 Mar; 25(1):167-77.
Score: 0.008